# Biolex Therapeutics, Inc.: Form D filings

Biolex Therapeutics, Inc., a biotechnology company in Pittsboro, NC, filed 4 Form D notices with the SEC between 2010 and 2011. The latest, on December 19, 2011, reports $2.4 million sold of a $3.2 million offering to 10 investors.

Find out what Biolex Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Biolex%20Therapeutics%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Biolex%20Therapeutics%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fbiolex-therapeutics-inc-1407698)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Biolex%20Therapeutics%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Biolex%20Therapeutics%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fbiolex-therapeutics-inc-1407698)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in North Carolina](https://specstream.ai/data/form-d/state/north-carolina): 984 rows, by operating companies, filed since November 1, 2024, $49.20, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/north-carolina
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 158 CREDLE STREET, Pittsboro, NC, 27312
- Phone: (919) 542-9901
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1407698

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Dec 19, 2011 | New notice | $3,200,000 | $2,364,417 | $835,583 | 10 | Dec 6, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1407698/000140769811000002/0001407698-11-000002-index.htm) |
| Jun 9, 2011 | New notice | $6,675,000 | $5,899,709 | $775,291 | 13 | May 27, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1407698/000140769811000001/0001407698-11-000001-index.htm) |
| Jul 30, 2010 | New notice | $10,000,000 | $8,677,852 | $1,322,148 | 13 | Jul 21, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1407698/000140769810000002/0001407698-10-000002-index.htm) |
| Feb 23, 2010 | New notice | $10,000,000 | $10,000,000 | $0 | 25 | Feb 11, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1407698/000140769810000001/0001407698-10-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| David P. Spencer | Executive Officer |  |
| Jan P. Turek | Executive Officer, Director |  |
| Kurt Page Graves | Executive Officer, Director |  |
| Dennis J. Dougherty | Director |  |
| David L. Castaldi | Director |  |
| P. Sherrill Neff | Director |  |
| Jeffrey Thomas Leiden | Director |  |
| Dale A. Sander | Executive Officer |  |
| W. Thomas Amick | Director |  |
| Liza Page Nelson | Director |  |

## Other biotechnology companies in North Carolina that filed recently

- [Toggle Bio](https://specstream.ai/data/form-d/company/toggle-bio-2158695) $200,000 · Oct 6, 2026
- [Swift Cardiovascular, Inc.](https://specstream.ai/data/form-d/company/swift-cardiovascular-inc-2117135) $810,000 · Sep 24, 2026
- [Aclarity Genomics, Inc.](https://specstream.ai/data/form-d/company/aclarity-genomics-inc-2153126) $4.6 million · Sep 2, 2026
- [Aer Therapeutics, Inc.](https://specstream.ai/data/form-d/company/aer-therapeutics-inc-1959576) $3 million · Aug 19, 2026

[Every Form D from the week of Dec 19, 2011](https://specstream.ai/data/form-d/week/2011-12-19) · [All recent filings in North Carolina](https://specstream.ai/data/form-d/state/north-carolina) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Biolex Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).